Breaking News Instant updates and real-time market news.

JNJ

Johnson & Johnson

$123.51

-0.44 (-0.35%)

13:34
05/07/17
05/07
13:34
05/07/17
13:34

Janssen reports real-word data on INVOKANA

Johnson & Johnson's Janssen announced Friday real-world evidence showing people with type 2 diabetes initiated on oral INVOKANA 300mg were as likely as matched patients initiated on injectable GLP-1 receptor agonists to achieve the recognized HEDIS standard of blood glucose control of A1C less than 8.0 percent. Patients on INVOKANA were also less likely to discontinue their medication or be prescribed a new antihyperglycemic agent. These findings were presented at the American Association of Clinical Endocrinologists' Annual Scientific & Clinical Congress. Specifically, the analysis showed: Patients with A1C levels of 8.0 percent or greater before starting either therapy had similar A1C levels at each 3-month interval post-index. Time to reach A1C below 8.0 percent was comparable with INVOKANA and GLP-1 RAs (12.4 months vs. 13.1 months). INVOKANA patients were 30 percent less likely to discontinue initial therapy compared to those initiating GLP-1 RAs, with a median time to discontinuation of 12.4 vs. 8.6 months, respectively. INVOKANA patients were 28 percent less likely to be prescribed a new AHA.

  • 06

    Jun

JNJ Johnson & Johnson
$123.51

-0.44 (-0.35%)

04/19/17
LEER
04/19/17
NO CHANGE
Target $140
LEER
Outperform
Johnson & Johnson price target lowered to $140 from $150 at Leerink
Leerink analyst Danielle Antalffy lowered her price target for Johnson & Johnson to $140 from $150 on valuation. The analyst notes that the shares sold off as investors seemed taken aback by weakness in both non-REMICADE Pharma and Consumer, but he points out that there are a number of potential drivers of an improving outlook going forward, including Medical Devices growth reacceleration, continued strong double-digit growth of key new drugs, and likely consumer growth reacceleration as the macroeconomic environment improves and with consumer confidence at its highest level in years. The analyst reiterates an Outperform rating on the shares.
04/24/17
BARD
04/24/17
NO CHANGE
Target $5
BARD
Outperform
Achillion price target lowered to $5 from $10 at Baird
Baird analyst Brian Skorney lowered his price target on Achillion (ACHN) to $5 from $10 on its disappointing Hep-C results, which indicated a weakness when it comes to genotype 3 patients. Although he expects partner Johnson & Johnson (JNJ) to push the trial into Phase 3, he think it makes the regimen a more difficult sell with other drugs offering genotype 3 efficacy. Skorney maintained his Outperform rating on Achillion shares.
04/25/17
JMPS
04/25/17
NO CHANGE
JMPS
Johsnson &Johnson data positive for Achillion, says JMP Securities
JMP Securities analyst Liisa Bayko says that data on a triple combination HCV treatment presented by Johnson & Johnson (JNJ) yesterday is positive for Achillion (ACHN). The analyst noted that the triple combination includes Achillion's odalasvir and that the six week treatment regimen is shorter than the eight weeks required for Gilead's (GILD) Harvoni. The analyst says that Achillion's stock dropped sharply yesterday because there was disappointment over the combination's efficacy in genotype 3 patients. However, she says that such patients only represent 10% of the total, and she says that Achillion can "conservatively" obtain peak royalty revenue of about $100M from its drug. Bayko keeps a $13 price target and an Outperform rating on the shares.
04/25/17
MAXM
04/25/17
NO CHANGE
Target $5
MAXM
Buy
Achillion price target lowered to $5 from $8 at Maxim
Maxim analyst Jason Kolbert said phase 2 trial results demonstrated that Achillion's (ACHN) triple combination of simeprevir, odalasvir and AL-335 has the ability to shorten treatment duration, be generally well tolerated and offer high efficacy for hepatitis C virus genotype 1 patients. While Johnson & Johnson (JNJ) is likely to move forward with this regimen, allowing Achillion to realize milestones, Kolbert has removed any royalties from his model as he expects others to dominate the landscape with "near perfect" regimens. Kolbert lowered his price target on Achillion to $5 from $8 but keeps a Buy rating on the shares.

TODAY'S FREE FLY STORIES

ITRM

Iterum Therapeutics

$0.00

(0.00%)

21:29
05/24/18
05/24
21:29
05/24/18
21:29
Syndicate
Iterum Therapeutics 6.15M share IPO priced at $13.00 »

The deal size was…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    May

UPL

Ultra Petroleum

$1.90

-0.14 (-6.86%)

21:27
05/24/18
05/24
21:27
05/24/18
21:27
Downgrade
Ultra Petroleum rating change  »

Ultra Petroleum…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

PBR

Petrobras

$12.77

-2.335 (-15.46%)

, EWZ

MSCI Brazil Index

$38.16

-0.52 (-1.34%)

20:57
05/24/18
05/24
20:57
05/24/18
20:57
Periodicals
Brazil president Temer says agreement with truckers was reached, Bloomberg says »

Temer says he expects the…

PBR

Petrobras

$12.77

-2.335 (-15.46%)

EWZ

MSCI Brazil Index

$38.16

-0.52 (-1.34%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ROST

Ross Stores

$82.95

0.35 (0.42%)

20:46
05/24/18
05/24
20:46
05/24/18
20:46
Recommendations
Ross Stores analyst commentary at Loop Capital »

Ross Stores price target…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    May

BMRN

BioMarin

$88.30

-0.2 (-0.23%)

20:41
05/24/18
05/24
20:41
05/24/18
20:41
Recommendations
BioMarin analyst commentary at Piper Jaffray »

BioMarin approval of…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    May

  • 12

    Sep

DECK

Deckers Brands

$103.63

0.8 (0.78%)

, SCVL

Shoe Carnival

$26.38

0.79 (3.09%)

20:30
05/24/18
05/24
20:30
05/24/18
20:30
Hot Stocks
On The Fly: After Hours Movers »

UP AFTER EARNINGS:…

DECK

Deckers Brands

$103.63

0.8 (0.78%)

SCVL

Shoe Carnival

$26.38

0.79 (3.09%)

CAVM

Cavium

$79.53

-0.4 (-0.50%)

DGX

Quest Diagnostics

$100.89

-0.34 (-0.34%)

BMRN

BioMarin

$88.30

-0.2 (-0.23%)

ZOES

Zoe's Kitchen

$14.48

-0.41 (-2.75%)

GPS

Gap

$32.97

1 (3.13%)

EGHT

8x8, Inc.

$22.00

0.35 (1.62%)

ADSK

Autodesk

$138.76

-0.54 (-0.39%)

ROST

Ross Stores

$82.95

0.35 (0.42%)

NTNX

Nutanix

$55.39

-0.85 (-1.51%)

SPLK

Splunk

$116.35

-0.2 (-0.17%)

VEEV

Veeva

$77.24

0.5 (0.65%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    May

  • 24

    May

  • 24

    May

  • 24

    May

  • 24

    May

  • 24

    May

  • 24

    May

  • 24

    May

  • 25

    May

  • 29

    May

  • 31

    May

  • 07

    Jun

  • 12

    Jun

  • 14

    Jun

  • 10

    Jul

  • 12

    Sep

FL

Foot Locker

$46.38

1.35 (3.00%)

, HIBB

Hibbett Sports

$28.95

0.6 (2.12%)

20:25
05/24/18
05/24
20:25
05/24/18
20:25
Earnings
Notable companies reporting before tomorrow's open »

Notable companies…

FL

Foot Locker

$46.38

1.35 (3.00%)

HIBB

Hibbett Sports

$28.95

0.6 (2.12%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    May

  • 25

    May

SNAP

Snap

$10.59

-0.045 (-0.42%)

20:06
05/24/18
05/24
20:06
05/24/18
20:06
Periodicals
Snap's Send and Request location feature aims to boost privacy, TechCrunch says »

Snapchat is taking…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 07

    Jun

MDT

Medtronic

$86.94

1.65 (1.93%)

19:52
05/24/18
05/24
19:52
05/24/18
19:52
Recommendations
Medtronic analyst commentary at Piper Jaffray »

Medtronic price target…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    May

  • 02

    Jun

  • 05

    Jun

  • 05

    Jun

  • 19

    Jun

  • 20

    Jun

  • 25

    Jun

  • 26

    Jun

MRK

Merck

$59.11

-0.05 (-0.08%)

, ESALY

Eisai

$0.00

(0.00%)

19:43
05/24/18
05/24
19:43
05/24/18
19:43
Hot Stocks
Eisai, Merck provide update on sNDA for Lenvatinib in HCC »

Eisai (ESALY). and Merck…

MRK

Merck

$59.11

-0.05 (-0.08%)

ESALY

Eisai

$0.00

(0.00%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 02

    Jun

  • 05

    Jun

  • 10

    Sep

  • 23

    Oct

MCD

McDonald's

$162.38

0.865 (0.54%)

19:18
05/24/18
05/24
19:18
05/24/18
19:18
Periodicals
McDonald's sued by customers over unwanted cheese on burgers, Miami Herald says »

Two South Forida…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    May

  • 30

    May

CNI

Canadian National

$83.75

-0.4 (-0.48%)

19:18
05/24/18
05/24
19:18
05/24/18
19:18
Upgrade
Canadian National rating change at Deutsche Bank »

Canadian National…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 30

    May

EXR

Extra Space Storage

$95.10

1.335 (1.42%)

19:11
05/24/18
05/24
19:11
05/24/18
19:11
Hot Stocks
Extra Space Storage raises quarterly dividend by 10.3% to 86c per share »

The dividend is payable…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

EWP

MSCI Spain Index ETF

$32.38

-0.075 (-0.23%)

, FXE

Euro Currency Trust

$112.60

0.2 (0.18%)

19:09
05/24/18
05/24
19:09
05/24/18
19:09
Periodicals
Spain opposition planning no-confidence vote for PM Rajoy, Bloomberg reports »

Spain's Socialist…

EWP

MSCI Spain Index ETF

$32.38

-0.075 (-0.23%)

FXE

Euro Currency Trust

$112.60

0.2 (0.18%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SSNLF

Samsung

$0.00

(0.00%)

, AAPL

Apple

$188.18

-0.18 (-0.10%)

18:48
05/24/18
05/24
18:48
05/24/18
18:48
Periodicals
Breaking Periodicals news story on Samsung, Apple »

Samsung says Apple…

SSNLF

Samsung

$0.00

(0.00%)

AAPL

Apple

$188.18

-0.18 (-0.10%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 10

    Sep

XOM

Exxon Mobil

$80.26

-1.88 (-2.29%)

18:43
05/24/18
05/24
18:43
05/24/18
18:43
Periodicals
Sonatrach CEO seeks cooperation with Exxon on shale gas, Reuters says »

Algerian state energy…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 30

    May

UAL

United Continental

$70.47

0.93 (1.34%)

18:39
05/24/18
05/24
18:39
05/24/18
18:39
Periodicals
United names former FAA chief Jane Garvey chairman, Bloomberg says »

United Continental's…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 30

    May

  • 07

    Jun

  • 13

    Jun

  • 26

    Jun

SPX

S&P 500

$0.00

(0.00%)

, SPY

SPDR S&P 500 ETF Trust

$272.87

-0.5 (-0.18%)

18:35
05/24/18
05/24
18:35
05/24/18
18:35
Periodicals
U.S. bill would force tech firms to reveal foreign software use, Reuters says »

Senate staff said that…

SPX

S&P 500

$0.00

(0.00%)

SPY

SPDR S&P 500 ETF Trust

$272.87

-0.5 (-0.18%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

EWY

iShares MSCI South Korea Index Fund

$73.49

-0.96 (-1.29%)

, SPY

SPDR S&P 500 ETF Trust

$272.87

-0.5 (-0.18%)

18:33
05/24/18
05/24
18:33
05/24/18
18:33
Periodicals
N Korea's KCNA press expressing regret over cancelled U.S. talks, Bloomberg says »

The report cites North…

EWY

iShares MSCI South Korea Index Fund

$73.49

-0.96 (-1.29%)

SPY

SPDR S&P 500 ETF Trust

$272.87

-0.5 (-0.18%)

EWJ

iShares MSCI Japan Index Fund

$60.34

-0.37 (-0.61%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

LMT

Lockheed Martin

$326.46

0.98 (0.30%)

18:30
05/24/18
05/24
18:30
05/24/18
18:30
Periodicals
Senate Committee draft bill precludes Turkey from buying F-35s, Reuters says »

The amendment to U.S.…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 30

    May

GXP

Great Plains Energy

$32.77

0.02 (0.06%)

, WR

Westar Energy

$54.59

0.35 (0.65%)

18:29
05/24/18
05/24
18:29
05/24/18
18:29
Hot Stocks
Great Plains-Westar Energy merger approved by KCC, MPSC »

Great Plains Energy (GXP)…

GXP

Great Plains Energy

$32.77

0.02 (0.06%)

WR

Westar Energy

$54.59

0.35 (0.65%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

UAL

United Continental

$70.47

0.93 (1.34%)

18:08
05/24/18
05/24
18:08
05/24/18
18:08
Hot Stocks
Boutique Air announces codeshare partnership with United Airlines »

Boutique Air announced a…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 30

    May

  • 07

    Jun

  • 13

    Jun

  • 26

    Jun

KRNY

Kearny Financial

$14.25

-0.1 (-0.70%)

18:05
05/24/18
05/24
18:05
05/24/18
18:05
Hot Stocks
Kearny Financial increases quarterly cash dividend to 4c per share »

Kearny Financial declared…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

YRD

Yirendai

$28.42

-0.33 (-1.15%)

18:02
05/24/18
05/24
18:02
05/24/18
18:02
Earnings
Yirendai reports Q1 adjusted income per ADS $1.72, consensus 99c »

Reports Q1 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    May

  • 30

    May

  • 10

    Sep

AAPL

Apple

$188.18

-0.18 (-0.10%)

, SSNLF

Samsung

$0.00

(0.00%)

17:59
05/24/18
05/24
17:59
05/24/18
17:59
Periodicals
Apple wins $539M award from Samsung in patent trial, Bloomberg reports »

A jury in San Jose,…

AAPL

Apple

$188.18

-0.18 (-0.10%)

SSNLF

Samsung

$0.00

(0.00%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 10

    Sep

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.